These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 23553501)
1. Incidence and bone biopsy findings of atypical femoral fractures. Tamminen IS; Yli-Kyyny T; Isaksson H; Turunen MJ; Tong X; Jurvelin JS; Kröger H J Bone Miner Metab; 2013 Sep; 31(5):585-94. PubMed ID: 23553501 [TBL] [Abstract][Full Text] [Related]
2. Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study. Eisenstein N; Kasavkar G; Bhavsar D; Khan FS; Paskins Z BMC Musculoskelet Disord; 2017 Jan; 18(1):29. PubMed ID: 28114975 [TBL] [Abstract][Full Text] [Related]
3. Bone Formation Parameters of the Biopsied Ilium Differ between Subtrochanteric and Diaphyseal Atypical Femoral Fractures in Bisphosphonate-Treated Patients. Kondo N; Fukuhara T; Watanabe Y; Miyasaka D; Yamamoto N; Sato H; Wada Y; Nakatsue T; Fujisawa J; Sakuma M; Imai N; Yoda T; Narita I; Endo N Tohoku J Exp Med; 2017 Dec; 243(4):247-254. PubMed ID: 29212985 [TBL] [Abstract][Full Text] [Related]
4. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study. Lim SJ; Yeo I; Yoon PW; Yoo JJ; Rhyu KH; Han SB; Lee WS; Song JH; Min BW; Park YS Osteoporos Int; 2018 Nov; 29(11):2427-2435. PubMed ID: 30039251 [TBL] [Abstract][Full Text] [Related]
5. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center. Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389 [TBL] [Abstract][Full Text] [Related]
6. Bone cross-sectional geometry is not associated with atypical femoral fractures in Asian female chronic bisphosphonate users. Chou AC; Ng AC; Png MA; Chua DT; Ng DC; Howe TS; Koh JS Bone; 2015 Oct; 79():170-5. PubMed ID: 26067179 [TBL] [Abstract][Full Text] [Related]
7. Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy. Qiu S; Dhaliwal R; Divine G; Warner E; Rao SD J Bone Miner Res; 2024 May; 39(4):417-424. PubMed ID: 38477744 [TBL] [Abstract][Full Text] [Related]
8. High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan. Sato H; Kondo N; Wakamatsu A; Kobayashi D; Nakatsue T; Wada Y; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I Rheumatol Int; 2019 Oct; 39(10):1803-1810. PubMed ID: 31385078 [TBL] [Abstract][Full Text] [Related]
9. Trends in the incidence of atypical femoral fractures and bisphosphonate therapy. Clout A; Narayanasamy N; Harris I J Orthop Surg (Hong Kong); 2016 Apr; 24(1):36-40. PubMed ID: 27122510 [TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates and the risk of atypical femur fractures. Black DM; Condra K; Adams AL; Eastell R Bone; 2022 Mar; 156():116297. PubMed ID: 34920168 [TBL] [Abstract][Full Text] [Related]
11. Outcomes between older adults with atypical and typical femoral fractures are comparable. Khow KS; Paterson F; Shibu P; Yu SC; Chehade MJ; Visvanathan R Injury; 2017 Feb; 48(2):394-398. PubMed ID: 27839798 [TBL] [Abstract][Full Text] [Related]
12. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur. Zanchetta MB; Diehl M; Buttazzoni M; Galich A; Silveira F; Bogado CE; Zanchetta JR J Bone Miner Res; 2014 Apr; 29(4):999-1004. PubMed ID: 24115250 [TBL] [Abstract][Full Text] [Related]
13. Bone turnover markers and the factors associated with atypical femur fractures among Japanese patients. Iizuka Y; Iizuka H; Kaneko T; Mieda T; Takechi R; Suzuki H; Sorimachi Y; Suto T; Tachibana M; Yoneyama T; Omodaka T; Hashimoto S; Hamano N; Sakane H; Shimoyama D; Kohama I; Ohshima A; Nozaki T; Kamiyama M; Moteki T; Ohshima A; Takamine S; Honda A; Ueno A; Tajika T; Okamura K; Warita T; Yonemoto Y; Shitara H; Ohsawa T; Takagishi K Injury; 2016 Nov; 47(11):2484-2489. PubMed ID: 27670281 [TBL] [Abstract][Full Text] [Related]
14. Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series. Andersen JD; Bünger MH; Rahbek O; Hald JD; Harsløf T; Langdahl BL Osteoporos Int; 2019 Feb; 30(2):513-517. PubMed ID: 30448959 [TBL] [Abstract][Full Text] [Related]
15. Trabecular Bone Score and Hip Structural Analysis in Patients With Atypical Femur Fractures. Buitendijk SKC; van de Laarschot DM; Smits AAA; Koromani F; Rivadeneira F; Beck TJ; Zillikens MC J Clin Densitom; 2019; 22(2):257-265. PubMed ID: 29661684 [TBL] [Abstract][Full Text] [Related]
16. Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society. van de Laarschot DM; McKenna MJ; Abrahamsen B; Langdahl B; Cohen-Solal M; Guañabens N; Eastell R; Ralston SH; Zillikens MC J Clin Endocrinol Metab; 2020 May; 105(5):1682-99. PubMed ID: 31867670 [TBL] [Abstract][Full Text] [Related]
17. Duration-Dependent Increase of Human Bone Matrix Mineralization in Long-Term Bisphosphonate Users with Atypical Femur Fracture. Farlay D; Rizzo S; Ste-Marie LG; Michou L; Morin SN; Qiu S; Chavassieux P; Chapurlat RD; Rao SD; Brown JP; Boivin G J Bone Miner Res; 2021 Jun; 36(6):1031-1041. PubMed ID: 33434290 [TBL] [Abstract][Full Text] [Related]
18. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration. Miller PD; McCarthy EF Semin Arthritis Rheum; 2015 Apr; 44(5):477-482. PubMed ID: 25312241 [TBL] [Abstract][Full Text] [Related]
19. Periprosthetic Atypical Femoral Fractures in Patients on Long-term Bisphosphonates: A Multicenter Retrospective Review. Robinson Jde D; Leighton RK; Trask K; Bogdan Y; Tornetta P J Orthop Trauma; 2016 Apr; 30(4):170-6. PubMed ID: 27003029 [TBL] [Abstract][Full Text] [Related]
20. Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years. Lo JC; Neugebauer RS; Ettinger B; Chandra M; Hui RL; Ott SM; Grimsrud CD; Izano MA BMC Musculoskelet Disord; 2020 Dec; 21(1):801. PubMed ID: 33272248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]